Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CalciMedica, Inc. - Common Stock (NQ: CALC )

3.820 -0.190 (-4.74%)
Streaming Delayed Price Updated: 10:11 AM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,193
Open 3.990
Bid (Size) 3.710 (1)
Ask (Size) 3.830 (1)
Prev. Close 4.010
Today's Range 3.710 - 3.990
52wk Range 1.750 - 8.380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024
CALC stock results show that CalciMedica beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Massively Undervalued 10-Bagger Stocks to Buy
Explore three massively undervalued stocks to buy, offering significant growth potential in the industrial and healthcare sectors. 
Via InvestorPlace

Performance

YTD
+24.63%
+24.63%
1 Month
-27.24%
-27.24%
3 Month
-15.39%
-15.39%
6 Month
-25.39%
-25.39%
1 Year
+6.11%
+6.11%

More News

Read More
CalciMedica And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
CALC Stock Earnings: CalciMedica Reported Results for Q4 2023
Via InvestorPlace
Top 4 Health Care Stocks That May Crash This Quarter
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Gannett And 3 Other Stocks Under $4 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
From CalciMedica
Via GlobeNewswire
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
CalciMedica Announces Relisting on Nasdaq
From CalciMedica
Via GlobeNewswire
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
From CalciMedica
Via GlobeNewswire
CalciMedica Expands Executive Team with New Appointments
From CalciMedica
Via GlobeNewswire
Houston American Energy And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Via Benzinga
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.